Wednesday, January 9, 2013

• Stem Cell Companies For Consideration In 2013at Seeking Alpha (Wed, Jan 9)

Tuesday, January 8, 2013

• Advanced Cell Technology Achieves Clinical MilestoneBusiness Wire (Tue, Jan 8)
• Looking Beyond The JPM Global Healthcare Conference: More Biotech Than Meets The Eyeat Seeking Alpha (Tue, Jan 8)

Monday, January 7, 2013

• Advanced Cell Technology to Present at Biotech Showcase™ 2013Business Wire (Mon, Jan 7)

Wednesday, January 2, 2013

• Stem Cells, Dr. Oz And A Potentially Lucrative Investment Opportunityat Seeking Alpha (Wed, Jan 2)

Thursday, December 20, 2012

• New Scientist Magazine Selects ACT’s Induced Pluripotent Stem (iPS) Cell-Derived Human Platelet Program As One of ‘10 Ideas That Will Shape The Year’Business Wire (Thu, Dec 20)

Wednesday, December 19, 2012

• Advanced Cell Technology Elects Not to Complete Reverse SplitBusiness Wire (Wed, Dec 19)

Monday, December 17, 2012

• ACT Announces Completion of Higher-Dosage Cohort in European Clinical Trial for Stargardt’s Macular DystrophyBusiness Wire (Mon, Dec 17)

Thursday, December 6, 2012

• ACTC And The Ghosts Of Christmasat Seeking Alpha (Thu, Dec 6)

Monday, December 3, 2012

• Advanced Cell Technology to Participate on Panels and Host Experts Luncheon at 2012 World Stem Cell SummitBusiness Wire (Mon, Dec 3)

Wednesday, November 28, 2012

• ACT Announces Completion of Higher-Dosage Cohort in Both U.S. Clinical TrialsBusiness Wire (Wed, Nov 28)

Monday, November 12, 2012

• Pennyland Biopharma Stocks: Value Or Value-Traps?at Seeking Alpha (Mon, Nov 12)

Saturday, November 10, 2012

• Advanced Cell Technology 's CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Sat, Nov 10)

Thursday, November 8, 2012

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)
• Advanced Cell Technology Announces Interim Data from Its Three Ongoing Macular Degeneration TrialsBusiness Wire (Thu, Nov 8)
• Advanced Cell Technology Announces 2012 Third Quarter ResultsBusiness Wire (Thu, Nov 8)

Monday, November 5, 2012

• Advanced Cell Technology to Announce Third Quarter Financial Results on Thursday, November 8thBusiness Wire (Mon, Nov 5)

Friday, October 26, 2012

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 10-K/A, Annual ReportEDGAR Online (Fri, Oct 26)

Tuesday, October 9, 2012

• Nobel Winner’s Stem Cells to Be Tested in Eye Malady in 2013at Bloomberg (Tue, Oct 9)

Monday, October 8, 2012

• The Potential Giant Killer That Is Advanced Cell Technologyat Seeking Alpha (Mon, Oct 8)

Thursday, September 20, 2012

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of EEDGAR Online (Thu, Sep 20)

Friday, September 14, 2012

• ADVANCED CELL TECHNOLOGY, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other EventsEDGAR Online (Fri, Sep 14)

Tuesday, September 4, 2012

• The Next Big Growth Sector In Health Care: Stem Cell Therapyat Seeking Alpha (Tue, Sep 4)

Monday, September 3, 2012

• 3 Speculative Biotech Stocks To Electrify Your Boring Portfolioat Seeking Alpha (Mon, Sep 3)

Wednesday, August 29, 2012

• Wall Street Transcript Interview with Aethlon Medical, Inc. (AEMD) CEO James A. JoyceWall Street Transcript (Wed, Aug 29)

Add ACTC News to My Yahoo!